YOKNEAM, Israel, December 18 CMT MedicalTechnologies Ltd ("CMT"), a specialist in high-resolution digital imagingsolutions for the medical industry announced today its Board of Directors areto support an offer made by Thales Group, a leading international electronicsand systems company, to purchase 50.1% to 100% of CMT shares at a price ofEUR5.65 per share, reflecting a Company value of EUR21.5 million.
Thales is a world leader in the manufacturing of components andsubsystems for professional applications, including hardware and software formedical radiology equipment. CMT will become an entity in the Thales Groupand business line, augmenting Thales' portfolio in the medical imaging sectorwith new products and pipeline potential. Thales' strong brand recognitionand reputation, as well as its worldwide sales and distribution network, willprovide more opportunities and increased visibility when marketing fulldigital imaging packages.
The offer reflects CMT's significant assets as a leading innovator anddeveloper of high-resolution digital imaging solutions, acknowledging thevalue of its highly trained managerial, research and technical staff.
Commenting on the offer, Chaya Greenberg, Chairwoman of the Board of CMT,said, "The Board of Directors and management team of CMT strongly supportthis offer by Thales. I am proud that a leading company like Thalesrecognizes the unique capabilities and future of CMT."
The CEO of CMT, Amit Meridor, added, "This offer by Thales, in line withthe long-term strategic plan outlined for CMT, will enable us to secure ourleadership in the field of medical imaging by leveraging our R&D strengthswith Thales' technological knowledge, as well as by opening new, much broaderchannels for sales and distribution of our products worldwide. Our employeeswill benefit greatly from the broad, dynamic global resource pool of Thaleswhile our customers will gain directly from the enlarged product and serviceofferings."
About CMT Medical Technologies Ltd.:
CMT Medical Technologies Ltd. is an Israeli company which designs,develops, manufactures and markets digital image processing systems for usein medical diagnostic imaging applications. CMT is also engaged in thedevelopment of X-ray detectors for various medical applications.
The company's stock is publicly traded on Eurolist of the Paris StockExchange. The company also belongs to EURONEXT Next Economy segment.Reuters: CMT.LN Bloomberg: CMTM Euroclear Paris code: 22023 If you wish to receive further information by e-mail, please contact: Mrs. Nadine Tomaschoff - CFO & Investor Relations at: email@example.com or +972-48-566-225
SOURCE CMT Medical Technologies